Co-Authors
This is a "connection" page, showing publications co-authored by Florian Klein and Philipp Schommers.
Connection Strength
1.151
-
Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nat Protoc. 2021 07; 16(7):3639-3671.
Score: 0.237
-
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe. 2021 06 09; 29(6):917-929.e4.
Score: 0.236
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 09 17; 182(6):1663-1673.
Score: 0.226
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 08 20; 182(4):843-854.e12.
Score: 0.223
-
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021 Jul; 6:100122.
Score: 0.059
-
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021 Mar 31; 9(4).
Score: 0.059
-
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients. Viruses. 2020 09 18; 12(9).
Score: 0.056
-
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill. 2020 05; 25(21).
Score: 0.055